Compumedics delivers record FY26 revenue, 72% EBITDA growth and strong cash generation.
25. August 2026
Compumedics Limited (ASX: CMP), is pleased to present the FY26 results and business update in conjunction with the release of its Appendix 4E preliminary final report for the year ended 30 June 2026.
> Download the FY26 Business Update
> Download the FY26 Preliminary Final Report
For further information please contact:
Dr David Burton
Executive Chairman, CEO
Compumedics Limited
Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399
David Lawson
Director, CFO
Compumedics Limited
Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399
Authorised for lodgement by Compumedics Limited’s Board of Directors